Epstein Secrets

evices suitable f=r working in developing countries, and may be powered and run by a cell phone or smart device. • Current CDC approved EZ1-RT-P=R Taqman assay has LOD of 5,000 PFU/ml. This works when patient is&nbs=;febrile, i.e. has overt symptoms and may be contagious. • Next level of assay needs

crobiology & Immunology Box 62 Rm B-406 Weill Cornell Medical College [email protected] <mailto: Linnie Golightly, MD Associate Professor of Clinical Medicine and Microbiology & Immunology Center for Global Health Division of Infectious Diseases Weill Cornell Medical College A Multiplex PCR/LDR Assay f

ricated devices that w=ll allow for electronic detection, obviating the need for expens=ve hardware used in most fluorescent detection schemes (i.e. Taqman a=says). As such, we are poised to combine these technologie= for rapidly identifying and providing quantitative viral load fo= all the VHF, Variol

Linnie Dr. Francis Barany Dept of Microbiology & Immunology Box 62 Rm B-406 Weill Cornell Medical College innie o ig y, Associate Professor of Clinical Medicine and Microbiology & Immunology Center for Global Health Division of Infectious Diseases Weill Cornell Medical College A Multiplex PCR/LDR Assay f

devices suitable f=r working in developing countries, and may be powered and run by a cell phone or smart device. • Current CDC approved EZ1-RT-P=R Taqman assay has LOD of 5,000 PFU/ml. This works when patient is&nbs=;febrile, i.e. has overt symptoms and may be contagious. • Next level of assay needs

appreciated, Francis & Linnie Dr. Francis Barany Dept of Microbiology & Immunology Box 62 Rm B-406 Linnie Golightly, MD Associate Professor of Clinical Medicine and Microbiology & Immunology Center for Global Health Division of Infectious Diseases Weill Cornell Medical College 2 EFTA_R1_01775911 EFTA02